March 12, 2020

The COVID-19 Pandemic and Health Innovation

Tuesday, March 17 at 11:30 AM-12:15 PM EDT

Innovations in Healthcare is adding a new session to its 2020 Digital Annual Forum to address a critical and timely topic for the health innovation community. The Digital Annual Forum, converted from the traditional live format, will be held virtually on Monday and Tuesday, March 16 & 17, 9 AM to 12PM EDT both days. Registration is free and open to the public.

The World Health Organization has formally declared COVID-19 to be a pandemic, and almost every country now faces enormous challenges in preparing for and responding to this public health emergency. Healthcare innovators, especially those operating in low-resource settings, are often at the front lines of care delivery and dealing with disease outbreaks. This session will focus on the role of the health innovation community in dealing with COVID-19:

What have we learned from other corona viruses?

  • How contagious, how fatal is COVID-19? How can we protect ourselves and our families without feeding the hysteria?
  • How can the health innovation community best contribute to fighting the spread of COVID-19?
  • Why are strong health systems critical for global health security?

Register now to be a part of this important discussion with:

  • Jonathan “Jono” D. Quick, MD, MPH, Adjunct Professor at the Duke Global Health Institute and author of The End of Epidemics
  • Don Goldmann, MD, Professor, Immunology and Infectious Diseases, and Epidemiology, Harvard TH Chan School of Public Health and Chief Scientific Officer, Emeritus, and Senior Fellow at the Institute for Healthcare Improvement http://www.ihi.org/
  • Diana Silimperi, MD, visiting professor of Global Health at Duke University https://globalhealth.duke.edu/

Moderator

Diana Silimperi, MD, is a public health pediatrician and epidemiologist. She brings more than 35 years of experience leading the design and implementation of integrated healthcare service delivery and health system strengthening programs in more than 50 countries in Africa, Asia, and Latin America. She has been a leader in critical public health strategies, including quality improvement and the role of front-line health workers. More recently she has championed the importance of private sector contributions to global health security, and the essential role of the community in early detection and response. Silimperi earned her BS in Zoology/Psychology and her MD from Duke University, where she was elected to Phi Beta Kappa and the Alpha Omega Alpha Honor Medical Society. She served as an EIS Officer in the CDC’s Arctic Investigation Lab focusing on infectious disease surveillance, followed by several years in Alaska as Medical Director of the Yukon Kuskokwim Health Corporation. Silimperi began her international career at Johns Hopkins, working in Bangladesh at the International Center for Diarrheal Disease Research. Since then, she has lived or worked in more than 30 countries and held leadership positions in several large global health development companies, including Senior Vice President for Global Health at Abt Associates. Silimperi joined DGHI in 2019 as a Visiting Professor in the Practice of Global Health, where she is working closely with the Education team to strengthen course offerings and learning experiences to better prepare graduates aimed at global health practitioner careers. She also contributes to the Duke Global Health Innovation Center and Innovations in Healthcare, focusing on transforming health systems to promote uptake and sustainability of cutting-edge health innovations.

 

Panelists

Jonathan “Jono” D. Quick, MD, MPH, is an Adjunct Professor at the Duke Global Health Institute and author of The End of Epidemics. Quick has served as President and CEO of Management Sciences for Health, Director of Essential Drugs and Medicines Policies at the World Health Organization, resident advisor for MSH in health system development and financing in Afghanistan and Kenya, and Chief of Staff/Clinical Director in the U.S. Public Health Service, Talihina, Oklahoma. He has carried out assignments to improve public health in more than 70 countries in Africa, Asia, Latin America, and the Middle East. He also holds appointments at Harvard Medical School and Boston University School of Public Health.  

He is creator of MDS-3: Managing Access to Medicines and Health Technologies and a contributor to The Financial Times Guide to Executive HealthPreventive Stress Management in Organizations. He has written more than 100 other books, chapters, and articles in leading medical journals. His op-eds, blogs and letters have appeared in TIME MagazineWall Street JournalThe GuardianNew York TimesMs. MagazineForbesHuffington Post,  and elsewhere. He has contributed to Trinity Forum Readings on the lives and faith of Ellen Johnson Sirleaf, Nelson Mandela, and human rights pioneer Bartolomé Las Casas. Quick has served on the board of directors for the Global Health Council, InterAction, Partnership for Supply Chain Management, and Clapham Servants. He was a resident and chief resident in the Duke Family Medicine program, graduated sum cum laude from Harvard College and received an MD with distinction in research and MPH from the University of Rochester. He was recently interviewed about COVID-19 for an article in The Guardian: https://www.theguardian.com/world/2020/mar/01/the-worst-case-scenario-for-coronavirus-dr-jonathan-quick-q-and-a-laura-spinney

 

Don Goldmann, MD, is a Professor of Pediatrics at Harvard Medical School and Professor of Immunology and Infectious Diseases, and Epidemiology at Harvard’s T.H. Chan School of Public Health. He is Chief Scientific Officer, Emeritus, and Senior Fellow at the Institute for Healthcare. Goldmann is a former member of CDC’s Epidemic Intelligence Service and helped develop infection prevention guidelines in the United States for the CDC and the Society for Healthcare Epidemiology of America and in low-resource countries for USAID. He has experience in responding to SARS and H1N1 and teaches a course on Infectious Diseases and Social Injustice at Harvard. One of the most significant consequences of COVID-19 is the disproportionate impact on the poor and disenfranchised around the world. As he says in his Harvard course, “The poor are the first to suffer and the first to be blamed.” Goldmann is Vice-Chair of the Advisory Committee of the Institute for Medicaid Innovation. He also serves on a number of advisory committees and boards, including the National Quality Forum’s Primary Care and Chronic Illness Standing Committee. He is a former Chair of the AHRQ National Advisory Council and the Board of Academy Health.